Skip to content

Factors influencing quality of life in cancer patients with medication related osteonecrosis of jaws

Study on analysis of factors affecting the Quality of life in cancer patients with Medication related osteonecrosis of Jaw - QOL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047753
Enrollment
30
Registered
2022-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z038- Encounter for observation for other suspected diseases and conditions ruled out

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Dr Sandeep Gurav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Confirmed MRONJ diagnosis as per AAOMS criteria. - Current or previous treatment with anti-resorptive or anti-angiogenic agents. - Exposed bone or bone that can be probed through an intraoral or extraoral fistula in the maxillofacial region for more than 8 weeks. - No history of radiation therapy to the jaws or obvious metastatic disease to the jaws. 2) Adult patients i.e., above 18 years 3) Patients willing to consent for participating in the study 4) Patients who are able to complete the questionnaire (in either English, Hindi, Marathi format)

Exclusion criteria

Exclusion criteria: 1) Metastatic lesions in the oral cavity. 2) Patients with cognitive impairment 3) Minors (below 18 years) 4) Pregnant women

Design outcomes

Primary

MeasureTime frame
To evaluate various factors affecting the quality of life in cancer patients with medication related osteonecrosis of jaw (MRONJ)- at a single time pointTimepoint: Single time point - Cross sectional study

Secondary

MeasureTime frame
To assess the dental status by using site specific, oral health impact profile â?? 14 (OHIP-14) quality of life questionnaire and oral hygiene index- simplified (OHI-S) in cancer patients with MRONJ.Timepoint: at single time point

Countries

India

Contacts

Public ContactDr Kiran Jagtiani

TATA MEMORIAL HOSPITAL

drsandeepgurav@gmail.com02224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026